Genetic Testing of Monogenic Hypertension in Chinese Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Monogenic hypertension, which follows the rules of Mendel's genetic law, is one of the most important causes of hypertension. Generally, patients occur hypertension in early age, have family history, and often manifest severe hypertension or refractory hypertension. At present, only a few hypertension centers of hospitals in China will help clinically difficult diagnosis hypertensive patients to test some selective genes, while most of other hospitals still perform diagnosis based on biochemical examination and clinical symptoms. Therefore, in order to provide better guidance for the diagnosis and treatment for hypertensive patients, this project aims to develop a single gene detection panel for genetic hypertension, so as to provide new diagnostic technology for early intervention, prevention and treatment of hypertension in clinics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetics of Hypertension and Its Intermediate Phenotypes

NCT00006499

Cardiovascular Diseases Hypertension

COMPLETED

Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension

NCT02988245

Hypertension

UNKNOWN PHASE2

Genetics in the Progression of Nephropathies

NCT06416761

AKI CKD Ckd-Mbd +5 more

RECRUITING

Genes of Hypertension in African Americans

NCT00063505

Cardiovascular Diseases Heart Diseases Hypertension

COMPLETED

Analysis of Genes That Predispose People to Develop High Blood Pressure

NCT00522119

Hypertension

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Monogenic Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hypertension patients meet one of the following criteria

1. Beginning age of hypertension: \<35 years (regardless of family history of hypertension);
2. refractory hypertension (blood pressure is difficult to control): triple antihypertensive drugs treatment for 1 months, 3 times of non-continuous high blood pressure in consulting room (SBP ≥140mmHg and/or DBP≥90mmHg);
* patients suspected of secondary hypertension, meeting one of the following criteria

1. pheochromocytoma or Cushing syndrome;
2. hypertension with hypokalemia;
3. hypertension with hyperkalemia;
4. hypertension with special body shape, such as central obesity, moon face, acne etc..
5. adrenal tumor;